{"url_path":"/fda/drug/recalls/D-0496-2026","section_key":"summary","section_title":"DRUG Recall: B BRAUN MEDICAL INC — DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-02","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0496-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"B BRAUN MEDICAL INC"},"word_count":80,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0496-2026\n\n**Recalling firm:** B BRAUN MEDICAL INC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-02\n**Report date:** 2026-04-29\n\n## Product\nDEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.\n\n## Reason\nLack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.\n\n## Affected lots\nLot # J5H166, J5H167, Exp Date: 30NOV2026.\n\n## Distribution\nUS Nationwide."}